Achondroplasia (ACH) is a skeletal dysplasia characterized by disproportionate short stature, resulting from the constitutive activation of fibroblast growth factor receptor 3 (FGFR3), with an estimated global prevalence of over 250,000 individuals [1,2]. The gene discussed is FGFR3; the disease is achondroplasia.